North America Molecular Biology Enzymes, Kits, and Reagents Market Overview and Growth by 2028

Historic Data: 2019-2020 | Base Year: 2021 | Forecast Period: 2022-2028

North America Molecular Biology Enzymes, Kits, and Reagents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Enzymes and Kits & Reagents), Application (Epigenetics, Sequencing, Synthetic Biology, Polymerase Chain Reaction, and Other), and End User (Biotechnological & Pharmaceutical Companies, Hospitals & Diagnostic Centers, and Academic & Research Institutes)

Report Date : Nov 2021
Report Code : TIPRE00025773

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 163

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

The molecular biology enzymes, kits, and reagents market in North America is expected to grow from US$ 5,532.13 million in 2021 to US$ 17,999.75 million by 2028; it is estimated to grow at a CAGR of 18.4% from 2021 to 2028.

The US, Canada, and Mexico are major economies in North America. Genomics getting highly funded is the major factor driving the growth of the North America molecular biology enzymes, kits, and reagents market. Genome sequencing was restricted to the research facilities, a few years back. However, it has now became one of the common techniques in clinical practices. Over the next few years, the healthcare sector is expected to generate genomic data of over 60 million patients. In August 2018, Nebula Genomics, a company based in Boston, Massachusetts, along with 10 leading venture capital firms, raised US$ 4.3 million in seed funding. as a part of partnership with Veritas Genetics, a genome sequencing company. The company aims to use these funds to create a trustworthy, secure, and decentralized marketplace for genomic data. Such continuous funding by the manufacturers and governments in the field of genomics is supporting the molecular biology enzymes, kits, and reagents market growth.

The outbreak of the COVID-19 pandemic situation shown some favorable scenario for players operating in the molecular biology enzymes, kits & reagents market. Various people across the North American region are affected with corona virus. For instance, the US is a highly affected country in the North American regions. The effect of the corona is mild in adults; however, it is adverse in older people. The infection of corona among older people has resulted in severe complications and has accounted for a good number of deaths in the country. But during the pandemic situation, life science companies engaged in development of novel drugs for the treatment of life threaten diseases. Therefore, molecular biology enzymes, kits & reagents products is required in drug design & development as well as COVID-19 diagnosis.

Furthermore, due to the rising numbers of COVID-19 population has positive impact on the molecular biology enzymes, kits & reagents market. In March 2021, Eurofins' Clinical Enterprise, Inc. has obtained an Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for a direct-to-consumer (DTC) version of its EmpowerDX COVID-19 Home Collection Kit. The Eurofins at-home COVID-19 nasal PCR kit is one of the first over-the-counter SARS-CoV-2 at-home test kits approved by the European Union. Thus, rising numbers of product launches support the growth of the market. Similarly, in July 2020, Eurofins U.S. Clinical Diagnostics has announced the availability of its pooled PCR test to detect SARS-CoV-2, which would substantially lower the cost per PCR test for clients.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America molecular biology enzymes, kits, and reagents market. The North America molecular biology enzymes, kits, and reagents market is expected to grow at a good CAGR during the forecast period.
25508-img1

This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

North America Molecular Biology Enzymes, Kits, and Reagents Market Segmentation

North America Molecular Biology Enzymes, Kits, and Reagents Market – By Product

Enzymes
- Polymerases
- Ligases
- Reverse Transcriptases
- Phosphatases
- Proteases and Proteinases
- Restriction Endonuclease
- Other
Kits and Reagents

North America Molecular Biology Enzymes, Kits, and Reagents Market – By Application

Epigenetics
Sequencing
Synthetic Biology
Polymerase Chain Reaction
Other

North America Molecular Biology Enzymes, Kits, and Reagents Market – By End User

Biotechnological and Pharmaceutical Companies
Hospitals and Diagnostic Centres
Academic and Research Institutes

North America Molecular Biology Enzymes, Kits, and Reagents Market, by Country

US
Canada
Mexico

North America Molecular Biology Enzymes, Kits, and Reagents Market - Companies Mentioned

Agilent Technologies, Inc.
F. HOFFMANN-LA ROCHE LTD
Illumina, Inc.
Merck KGAA
MERIDIAN BIOSCIENCE, INC
Promega Corporation
Qiagen
Rockland Immunochemicals Inc
THERMO FISHER SCIENTIFIC INC

North America Molecular Biology Enzymes, Kits, and Reagents Report Scope

Report Attribute	Details
Market size in 2021	US$ 5,532.13 Million
Market Size by 2028	US$ 17,999.75 Million
Global CAGR (2021 - 2028)	18.4%
Historical Data	2019-2020
Forecast period	2022-2028
Segments Covered	By Product Enzymes and Kits & Reagents By Application Epigenetics Sequencing Synthetic Biology Polymerase Chain Reaction By End User Biotechnological & Pharmaceutical Companies Hospitals & Diagnostic Centers Academic & Research Institutes
Regions and Countries Covered	North America US Canada Mexico
Market leaders and key company profiles	Agilent Technologies, Inc. F. HOFFMANN-LA ROCHE LTD Illumina, Inc. Merck KGAA MERIDIAN BIOSCIENCE, INC Promega Corporation Qiagen Rockland Immunochemicals Inc THERMO FISHER SCIENTIFIC INC

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the North America Molecular Biology Enzymes, Kits, and Reagents Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

North America Molecular Biology Enzymes, Kits, and Reagents Market Report Snapshots

Our Top Trending Reports

Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

Yukihiko Adachi CEO, Deep Blue, LLC.

Reason to Buy

Informed Decision-Making
Understanding Market Dynamics
Competitive Analysis
Customer Insights
Market Forecasts
Risk Mitigation
Strategic Planning
Investment Justification
Identifying Emerging Markets
Enhancing Marketing Strategies
Boosting Operational Efficiency
Tracking Industry Innovations
Aligning with Regulatory Trends

Your Key Concerns Addressed - Question & Answer

Can I view a sample of the report before purchasing?

Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

Is analyst support included with the purchase?

Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

What are the next steps once I place an order?

Once your order is successfully placed, you will receive a confirmation email along with your invoice.

• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

Can the report be tailored to suit my specific needs?

We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

In what format is the report delivered?

The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

How secure is the payment process on your platform?

Our payment process is fully secure and PCI-DSS compliant.

We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.

Do you provide special pricing for buying multiple reports?

Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

Can I connect with your team to discuss the report before buying?

Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

Will I get a billing invoice upon purchase?

Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

Is there support available if I can’t access my report?

Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

Buy Now

87-673-9708

ISO 9001:2015